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program. Patients with mental disorders were 
excluded from the study.
Interview Phone interviews were performed 
by experienced PH physicians who routinely 
took care of the study patients. At least 2 at‑
tempts were made on 2 different days to con‑
tact every patient.
Questionnaire We used a questionnaire com‑
prised of 2 question panels. In the first pan‑
el, we asked about the presence of alarming 
symptoms, which had appeared or exacerbat‑
ed since March 20, 2020. If the response was 
positive, the patient was requested to report 
their duration. In the second panel, we asked 
patients who had experienced alarming symp‑
toms about any medical contact they had (in 
person or by phone). Additionally, they were 
asked about the  fear associated with medi‑
cal contact caused by the COVID‑19 epidemic, 
the time of the potential delay between symp‑
tom occurrence and first medical contact, and 
the impact that the COVID‑19 epidemic had 
on the patients’ decisions. Similar questions 
were also asked in patients who did not report 
any alarming symptoms. Additionally, each pa‑
tient was asked if he or she had been diagnosed 
with COVID‑19.
Medical assessment After contacting each pa‑
tient, based on the reported complaints, the in‑
terviewing physician was expected to assess 
whether an office visit or hospitalization was in‑
dicated. Additionally, the physician was asked 
whether postponing medical contact would have 
a negative impact on the patient’s prognosis.
Introduction Pulmonary arterial hyperten‑
sion (PAH, group 1) and chronic thromboembol‑
ic pulmonary hypertension (CTEPH, group 4) 
are rare diseases of the pulmonary vascular sys‑
tem resulting in progressive heart failure and 
ultimately death. Poor prognosis of patients 
with PAH and CTEPH is reflected by progressive 
clinical symptoms including decreased physical 
capacity, exertional dyspnea, peripheral edema, 
ascites, cyanosis, and recurrent syncope.1‑8 Due 
to the recent coronavirus disease 2019 (COV‑
ID‑19) pandemic, patients with cardiopulmo‑
nary diseases have been advised against non‑
essential medical contacts in order to mini‑
mize the risk of infection and life ‑threatening 
complications.9 However, patients with pulmo‑
nary hypertension (PH) are characterized by 
high morbidity and mortality risk due to their 
condition itself, and they are thus expected to 
contact healthcare providers in case of symp‑
tom exacerbation.10 ‑12
In the present study, we aimed to analyze 
decisions taken by patients with PAH and 
CTEPH regarding the use of medical resourc‑
es in response to clinical deterioration at the 
time of the COVID‑19 pandemic and to esti‑
mate the magnitude of unjustifiable delay in 
seeking medical contact.
Methods Study group We interviewed pa‑
tients with PAH and CTEPH treated in a single 
high ‑volume reference center for PH. Eligible pa‑
tients were diagnosed with PH before March 20, 
2020, the day when the COVID‑19 epidemic was 
officially announced by the Polish government. 
Patients were included in the study if they were 
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 FIGURE 1 Impact of the coronavirus disease 2019 (COVID‑19) pandemic on healthcare ‑seeking behaviors in patients with pulmonary arterial hypertension (PAH) 
and chronic thromboembolic pulmonary hypertension (CTEPH)
 Abbreviations: IQR, interquartile range; M, male; F, female
Patients
PAH (n = 105) and CTEPH (n = 56)
Telephone interview





























Fear of contact with healthcare due to 
the COVID-19 epidemic
The patient had indications for hospitalization 
or an offi  ce visit 
The COVID-19 epidemic infl uenced / would infl uence 
the decision to contact healthcare
Lack of medical contact might negatively impact 
the patient’s prognosis
The COVID-19 epidemic resulted in delayed contact 
with healthcare 
Delay time, d, median (IQR)
n = 139 (51 M, 88 F)
Median (IQR) age, 
63.9 (47.1–75.6) years
PAH (n = 90), CTEPH (n= 49)
n = 22 (6 M, 16 F)
Median (IQR) age, 
61.9 (53.7–69.9) years
PAH (n = 15), CTEPH (n = 7)
n = 7 (2 M, 5 F)
Median (IQR) age, 
55.3 (50.8–60.9) years
PAH (n = 6), CTEPH (n = 1)
n = 15 (4 M, 11 F)
Median (IQR) age, 
64.4 (57.1–72.6) years
PAH (n = 9), CTEPH (n = 6)
Results and discussion Study patients In our 
database, we identified 124 patients with PAH 
and 61 with CTEPH, all of Caucasian origin, 
who fulfilled the inclusion criteria. Between 
March 20, 2020 and April 24, 2020, we reached 
by phone 105 patients with PAH (men, 30 [29%]) 
Statistical analysis Categorical variables were 
presented as numbers and percentages, and con‑
tinuous variables, as medians and interquartile 
ranges. The study protocol was reviewed and ac‑
cepted by the Bioethical Committee of the Cham‑
ber of Physicians and Dentists in Kraków, Poland.













































at a median (interquartile range) age of 59.2 
(43.3–71) years, and 56 patients with CTEPH 
(men, 27 [48.2%]) at a median (interquartile 
range) age of 70.8 (61.3–77.1) years. No cases of 
COVID‑19 were reported in this group.
Symptoms of clinical deterioration A group of 
22 patients (13.7%) reported at least 1 symp‑
tom of clinical deterioration including exacerba‑
tion of exertional dyspnea (17 patients [77.2%]), 
followed by new or increased peripheral edema 
(9 [41%]), ascites (1 [4.5%]), cyanosis (2 [9%]), 
and hemoptysis (1 [4.5%]).
Response to alarming symptoms Only 7 patients 
(32%) who experienced clinical exacerbation con‑
tacted healthcare providers. In FIGURE 1, we show 
how the COVID‑19 pandemic has influenced 
healthcare ‑seeking behavior in patients with 
PAH and CTEPH. About half of the study pa‑
tients experienced fear of contacting the health‑
care system and decided to delay or avoid medi‑
cal contact because of the pandemic.
Medical assessment As assessed by the inter‑
viewing physicians, 10 patients (66.7%) who 
did not contact health service despite alarming 
symptoms had an indication for hospitalization 
or an office visit. Additionally, lack of medical 
contact in 5 patients was considered to nega‑
tively impact their prognosis.
Conclusions The COVID‑19 pandemic has result‑
ed in altered healthcare ‑seeking behaviors and 
fear of medical contact in the population of pa‑
tients with PAH and CTEPH, leading to avoidance 
of medical contact despite signs of clinical wors‑
ening. Advised strict social distancing resulted in 
the absence of reported cases of COVID‑19, yet 
at the expense of neglecting PH symptoms that 
may affect patients’ prognosis. Similar conclu‑
sions have come from 2 recent studies present‑
ing a decline in the number of patients with myo‑
cardial infarction admitted to hospitals13 and 
a marked increase in the time14,15 from the on‑
set of myocardial infarction symptoms to first 
medical contact during the COVID‑19 pandemic. 
Our study results call for communicating with 
high ‑risk groups and providing them with clear 
instructions on healthcare ‑seeking behaviors in 
this time of epidemic threat.
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